CUSIP G9TY5A101CLASS A ORD SHSZURAQ4 2025
39 filings · latest Mar 2, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 5.57M | $29.17M |
| 2 | Vr Adviser, LLC | 5.35M | $28.01M |
| 3 | Jpmorgan Chase & Co | 4.47M | $23.44M |
| 4 | Great Point Partners LLC | 3.82M | $20.00M |
| 5 | Braidwell LP | 3.18M | $16.67M |
| 6 | Pfizer Inc | 2.97M | $15.56M |
| 7 | Adage Capital Partners Gp, L.L.C. | 2.75M | $14.41M |
| 8 | Affinity Asset Advisors, LLC | 1.81M | $9.50M |
| 9 |
| 4 | Jan 27, 2026 | Athanor Capital | 13D | 15.7% | — | SEC |
| 5 | Jan 2, 2026 | Athanor Capital | 13G | 15.7% | 11.58M | SEC |
| 6 | Nov 14, 2025 | Great Point Partners, LLC | 13G/A | 5.9% | 3.82M | SEC |
| 7 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | 0.4% | 259.0K | SEC |
| 8 | Aug 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.9% | 6.35M | SEC |
| 9 | Aug 14, 2025 | Deep Track Capital, LP | 13G/A | 7.1% | 4.62M | SEC |
| 10 | Jul 16, 2025 | Jpmorgan Chase &Amp; Co. | 13G | 7.5% | 4.67M | SEC |
See the full Schedule 13D/13G history for Zura Bio Ltd.
Unlock full history| 1.56M |
| $8.17M |
| 10 | Morgan Stanley | 1.51M | $7.91M |